What is the management for chicken pox?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Chickenpox (Varicela)

Antiviral therapy with aciclovir should be initiated as soon as possible, preferably within 24 hours of rash onset, at a dose of 20 mg/kg (maximum 800 mg) 4 times daily for 5-7 days in patients who are at risk for complications. 1, 2

Indications for Antiviral Treatment

  • Treatment should be considered for the following high-risk groups:
    • Patients over 12 years of age 2
    • Immunocompromised individuals 2, 1
    • Patients with chronic cutaneous or pulmonary disorders 2
    • Patients receiving long-term salicylate therapy 2
    • Patients receiving corticosteroid therapy 2
    • Secondary household contacts of infected children 2

Dosing Recommendations

Oral Aciclovir

  • Children <45 kg: 20 mg/kg (maximum 400 mg/dose) 3-4 times daily for 5-10 days 2
  • Adults and adolescents: 800 mg orally 4-5 times daily for 7-10 days 2, 1
  • Continue treatment until no new lesions appear for 48 hours 2

Intravenous Aciclovir

  • For severe disease or immunocompromised patients: 10 mg/kg IV every 8 hours 1, 2
  • Some experts dose by body surface area in children >1 year: 500 mg/m²/dose IV every 8 hours 2

Symptomatic Management

  • Maintain adequate hydration 3
  • Use acetaminophen (paracetamol) for fever control 4, 5
  • Avoid NSAIDs (ibuprofen) due to potential increased risk of severe bacterial skin infections 4, 5
  • Topical calamine lotion or antihistamines may help relieve itching 5
  • Keep fingernails short and clean to prevent secondary bacterial infection from scratching 5

Special Populations

Immunocompromised Patients

  • Require more aggressive treatment with intravenous aciclovir 1, 2
  • Immunomodulator therapy should be discontinued in severe cases if possible 6
  • Immunomodulator therapy can be reintroduced after all vesicles have crusted over and fever has resolved 6

Post-Exposure Prophylaxis

  • Susceptible individuals exposed to chickenpox should receive varicella zoster immune globulin (VZIG) within 96 hours of exposure 6, 1
  • If VZIG is unavailable, a 7-day course of aciclovir starting 7-10 days after exposure may be considered 1

Infection Control Measures

  • Isolate patients with active chickenpox until all lesions have crusted over 6
  • Healthcare workers with no evidence of immunity who are exposed to VZV should receive post-exposure vaccination and be furloughed from days 10-21 after exposure 6
  • Healthcare workers with active lesions should avoid contact with susceptible individuals until all lesions resolve 6

Clinical Pearls and Pitfalls

  • Early treatment (within 24 hours of rash onset) is crucial for maximizing effectiveness of antiviral therapy 1, 7
  • Aciclovir does not eradicate latent virus or affect subsequent risk of herpes zoster 2
  • Dosage adjustment is required in patients with renal impairment 3
  • Severe complications can include pneumonia, central nervous system infection, and secondary bacterial infections 5
  • Symptomatic treatment alone is usually adequate for healthy children with uncomplicated chickenpox 8

Vaccination

  • Vaccination is recommended for susceptible individuals but should not be administered to immunocompromised patients due to risk of disseminated viral infection 6
  • Household contacts of susceptible immunocompromised individuals should be vaccinated if they are seronegative for HIV and have no history of chickenpox 6

By following these guidelines, most cases of chickenpox can be managed effectively with minimal complications. The key is early recognition and appropriate treatment for those at higher risk of severe disease.

References

Guideline

Tratamiento de la Varicela

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Aciclovir Treatment Guidelines for Chickenpox

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

BET 2: NSAIs and chickenpox.

Emergency medicine journal : EMJ, 2018

Research

Nursing management of childhood chickenpox infection.

Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of varicella in the immunocompetent adult.

Journal of medical virology, 1993

Research

Therapeutic approach to chickenpox in children and adults--our experience.

Medical archives (Sarajevo, Bosnia and Herzegovina), 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.